Analysis of novel p300/GATA4 binding complex druing cardiomyocyte hypertrophy by proteomics approach
| Project/Area Number |
24890191
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | University of Shizuoka |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2012-08-31 – 2014-03-31
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 心肥大 / 転写因子 / GATA4 / p300 / 翻訳後修飾 / RbAp48 / RbAp46 |
|---|
| Research Abstract |
A zinc finger protein GATA4 is associates with an intrinsic histone acetyltransferase p300 and regulates myocardial transcriptional activities in response to hypertrophic stimuli. We found that Retinoblastoma protein (Rb)-associated protein 48 and 46 (RbAp48/46) are novel component of the p300/GATA4 complex and form a repressor complex with HDACs in cardiomyocytes. RbAp48/46 could bind to GATA4, mediate the binding of HDAC1/2 with GATA4, and inhibited phenylephrine-induced hypertrophic responses such as acetylation of GATA4, activation of the ANF and ET-1 promoters, and increase in cell size. On the contrary, knockdown of RbAp48/46 by shRNA augmented such responses. Knockdown of HDAC1/2 augmented PE-induced hypertrophy and failed to inhibitory effects by RbAp48/46.
These findings demonstrate that RbAp48/46 recruit HDAC1/2 onto GATA4, suppress the binding of p300 with GATA4, and inhibit hypertrophic responses in cardiomyocytes.
|
Report
(3 results)
Research Products
(27 results)
-
[Journal Article]2013
Author(s)
Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, Watanabe Y, Suzuki H, Doi O, Suzuki K, Yamauchi M, Yokoji T, Miyoshi-Morimoto E, Otsuka Y, Hamada T, Imaizumi A, Nonaka Y, Fuwa T, Teramoto T, Kakeya H, Wada H, Hasegawa K
-
Journal Title
Biol Pharm Bull
Volume: 96
Pages: 1708-1714
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
